Stocks · Health care · Pharmaceutical Preparations

PHIBRO ANIMAL HEALTH CORP

PAHC Clue Score66
United States Fiscal year ends June CIK 0001069899 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Jack Bendheim
16 Apr 2026
President and CEO
Sold after exercise indirect
1,850
$54.88
$101.52K
Jack Bendheim
16 Apr 2026
President and CEO
Sold after exercise indirect
5,190
$54.56
$283.14K
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
19,138
$49.57
$948.71K
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
46,275
$48.65
$2.25M
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
38,209
$47.91
$1.83M
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
3,171
$46.68
$148.03K
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
3,640
$45.42
$165.34K
Jack Bendheim
5 Feb 2026
President and CEO
Sold after exercise indirect
409
$44.47
$18.19K
Jack Bendheim
4 Feb 2026
President and CEO
Sold after exercise indirect
3,520
$41.15
$144.86K
Jack Bendheim
14 Jan 2026
President and CEO
Sold after exercise indirect
393
$41.14
$16.17K
Jack Bendheim
14 Jan 2026
President and CEO
Sold after exercise indirect
3,258
$40.46
$131.82K
Jack Bendheim
3 Dec 2025
President and CEO
Sold after exercise indirect
3,520
$40.77
$143.51K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 32
Sales on a Rule 10b5-1 plan 93
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 651,431
History held since 16 Apr 2014